Methods | Randomised, double-blind, parallel-group, duration 2 days Medication given when pain ≥ moderate |
Participants | Postoperative pain M and F, age ≥ 20 years N = 616 |
Interventions | Celecoxib Etodolac Placebo Doses not given |
Outcomes | Patient impression Pain intensity, pain intensity difference Discontinuation due to lack of efficacy Adverse events |
Notes | May not have single-dose data Primary completion date November 2010 |